Published on Wednesday March 26, 2014
Performed a bioequivalence study
Smooth Drug Development has performed a bioequivalence study with a combination of antiretroviral drugs used in HIV treatment.
The human immunodeficiency virus (HIV) is a lentivirus (slowly replicating retrovirus) that causes the acquired immunodeficiency syndrome (AIDS), a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive.
HIV is a burden to countries' healthcare, social and financial security.